Appointments and Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Contact us
Find Clinical Trials

We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. 

Search Pediatric Cancer and Blood Disorder Clinical Trials
Our Affiliations
HMS Affiliate

Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.

Our Affiliations

Rachael Grace, MD, MMSc

  • Director, Hematology Clinic
  • Blanche P. Investigatorship in Hematology
  • Physician
  • Associate Professor of Pediatrics, Harvard Medical School

Office Phone

  • 617-355-8246

Appointment Phone

  • 617-355-8246, ext. 1

Fax

  • 617-730-0934

General

Treatment Centers

Discipline

Clinical Interests

Anemias, Hematology, Hemolytic anemia, Immune thrombocytopenia (ITP), Lymphadenopathy, Neutropenia, Pyruvate kinase deficiency, Sickle cell disease, Thrombosis

Location

Background

Board Certifications

  • Pediatric Hematology/Oncology
  • Pediatrics

Fellowship

  • Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology

Residency

  • Boston Combined Residency Program, Boston Children's Hospital/Boston Medical Center, Pediatrics

Medical School

  • Brown University School of Medicine

Biography

Rachael Grace, MD, MMSc, is a pediatric hematologist and clinical researcher at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center. She is the medical director of both the Hematology Ambulatory Program and the Hematology Clinical Research Program. Dr. Grace enjoys clinical care of pediatric patients and her research interests are focused on improving outcomes in the care and treatment of individuals with immune cytopenias.Dr. Grace is the lead investigator for the Pyruvate Kinase Deficiency Natural History Study, a global registry for patients with PK deficiency. She is a site investigator of the DRIVE-PK and ACTIVATE mitapivat (AG-348) clinical trials and the PEAK registry. She is also involved in multiple clinical research studies in immune cytopenias and is the director of the coordinating center for the ITP Consortium of North America (ICON), a research network of pediatric idiopathic thrombocytopenic purpura investigators from over 50 institutions in the U.S. and Canada.Dr. Grace is an Associate Professor of Pediatrics at Harvard Medical School. She received her MD at Brown University and received her master's degree in clinical research at Harvard Medical School. Dr. Grace completed her residency at Boston Children's Hospital and completed her pediatric hematology/oncology fellowship at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.